Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb;65(2):390-394.
doi: 10.1111/jgs.14498. Epub 2016 Nov 7.

Use of Bladder Antimuscarinics in Older Adults with Impaired Cognition

Affiliations

Use of Bladder Antimuscarinics in Older Adults with Impaired Cognition

Ariel R Green et al. J Am Geriatr Soc. 2017 Feb.

Abstract

Objective: To examine the use of antimuscarinics for treating urinary incontinence (UI) in older adults with varying levels of cognition.

Design: Cross-sectional.

Setting: National Alzheimer's Coordinating Center from 2005 through 2015.

Participants: Community-dwelling men and women aged 65 and older (N = 24,106).

Measurements: Clinicians and staff evaluated each participant's dementia status during annual in-person assessments. Participants or their informants reported all medications taken in the 2 weeks before each study visit.

Results: Overall, 5.2% (95% confidence interval (CI) = 4.9-5.5%) of the cohort took a bladder antimuscarinic. Participants with impaired cognition were more likely to be taking an antimuscarinic than those with normal cognition. Rates of bladder antimuscarinic use were 4.0% (95% CI = 3.6-4.4%) for participants with normal cognition, 5.6% (95% CI = 4.9-6.3%) for those with mild cognitive impairment, and 6.0% (95% CI = 5.5-6.4%) for those with dementia (p < .001). Of 624 participants with dementia who took antimuscarinics, 16% (95% CI = 13-19%) were simultaneously taking other medicines with anticholinergic properties.

Conclusion: Use of bladder antimuscarinics was more common in older adults with impaired cognition than in those with normal cognition. This use is despite guidelines advising clinicians to avoid prescribing antimuscarinics in individuals with dementia because of their vulnerability to anticholinergic-induced adverse cognitive and functional effects. A substantial proportion of cognitively impaired individuals who took antimuscarinics were simultaneously taking other anticholinergic medications. These findings suggest a need to improve the treatment of UI in individuals with impaired cognition.

Keywords: anticholinergic; dementia; urinary incontinence.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None.

Figures

Figure 1
Figure 1
Use of bladder antimuscarinics according to cognitive status, assessed at the last visit.
Figure 2
Figure 2
Annual prevalence of bladder antimuscarinic use according to cognitive status.

Comment in

Similar articles

Cited by

References

    1. Campbell NL, Boustani MA. Adverse cognitive effects of medications: Turning attention to reversibility. JAMA Intern Med. 2015;175:408–409. - PMC - PubMed
    1. Luo X, Chuang CC, Yang E, et al. Prevalence, management and outcomes of medically complex vulnerable elderly patients with urinary incontinence in the United States. Int J Clin Pract. 2015;69:1517–1524. - PMC - PubMed
    1. Sexton CC, Coyne KS, Thompson C, et al. Prevalence and effect on health-related quality of life of overactive bladder in older Americans: Results from the Epidemiology of Lower Urinary Tract Symptoms Study. J Am Geriatr Soc. 2011;59:1465–1470. - PubMed
    1. Brown JS, Vittinghoff E, Wyman JF, et al. Urinary incontinence: Does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc. 2000;48:721–725. - PubMed
    1. Gnanadesigan N, Saliba D, Roth CP, et al. The quality of care provided to vulnerable older community-based patients with urinary incontinence. J Am Med Dir Assoc. 2004;5:141–146. - PubMed

Substances